The MOTION study: a randomized, Phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor

Future Oncology, Ahead of Print.

Source: Future Oncology - August 18, 2023 Category: Cancer & Oncology Authors: William D Tap Maitreyi G Sharma Marc Vallee Bryan D Smith Matthew L Sherman Rodrigo Ruiz-Soto Michiel van de Sande R Lor Randall Nicholas M Bernthal Hans Gelderblom Source Type: research